High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
Backgrounds Lung adenocarcinoma is a complex disease that results in over 1.8 million deaths a year. Recent advancements in treating and managing lung adenocarcinoma have led to modest decreases in associated mortality rates, owing in part to the multifactorial etiology of the disease. Novel prognos...
Main Authors: | Mingrui Shao, Shize Yang, Siyuan Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/10560.pdf |
Similar Items
-
MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
by: Zhenzhen Wu, et al.
Published: (2022-05-01) -
UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells
by: Yanyan Luo, et al.
Published: (2023-09-01) -
HOXC10 Promotes the Metastasis of Human Lung Adenocarcinoma and Indicates Poor Survival Outcome
by: Xiao-Lei Tang, et al.
Published: (2017-08-01) -
Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation
by: Mingxi Jia, et al.
Published: (2022-10-01) -
Cell-Cycle-Regulated Interaction between Mcm10 and Double Hexameric Mcm2-7 Is Required for Helicase Splitting and Activation during S Phase
by: Yun Quan, et al.
Published: (2015-12-01)